Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

NUDT2 Associated Syndrome with Developmental Delay and Peripheral Neuropathy.
Neuromuscular and Clinical Neurophysiology (EMG)
P14 - Poster Session 14 (8:00 AM-9:00 AM)
1-009
To describe a case of NUDT2 mutation in a 23-years old male along with his younger sister and need for consideration of this mutation in similar cases with intellectual disability and developmental delays.

The NUDT2 gene, located on the chromosome 9, encodes the NUDIX Hydrolase 2 enzyme. Mutations in NUDT2 have been linked to intellectual disability and developmental delays.

We report case of a 23-year-old man with cognitive and motor developmental delays presenting with distal upper and lower extremity weakness. Symptoms started at age 6 months. Similar symptoms were found in his 10-year-old sister. No parental consanguinity was reported.

Motor examination showed atrophy and weakness of the dorsiflexors and plantar flexors along with diminished reflexes and an everted steppage gait. Sensory examination was abnormal with decreased pinprick and vibration sense in the legs and hands bilaterally. Neurocognitive testing indicated mild intellectual disability with FSIQ of 60.

MRI of the brain and spine and genetic testing for various neurological disorders was unrevealing. Sural nerve biopsy showed chronic neuropathy with large/small myelinated fiber loss. Vastus lateralis biopsy demonstrated mild denervation changes. Electromyography studies of the upper and lower extremities showed severe sensorimotor polyneuropathy with axonal and demyelinating features. Whole genome sequencing identified a homozygous frameshift variant in NUDT2 (c.186delA,p.Ala63Glnfs*3). The patient’s affected sister was found to harbor the same homozygous variant while both parents were identified as carriers.

We report a case of neurodevelopmental disease with cognitive and motor delay and peripheral neuropathy secondary to a homozygous frameshift in the NUDT2 gene, thus extending the previously reported phenotype. Mutation of NUTDT2 should be considered in patients presenting with intellectual disability with or without motor delay and peripheral neuropathy.

Authors/Disclosures
Shrikant Mishra, MD
PRESENTER
Dr. Mishra has nothing to disclose.
Shaweta Khosa Ms. Khosa has nothing to disclose.
Hane Lee, PhD (UCLA) Dr. Lee has nothing to disclose.
No disclosure on file
Frank Diaz, MD, PhD (Cedars-Sinai Medical Center) Dr. Diaz has nothing to disclose.
Robert Freundlich, MD Dr. Freundlich has nothing to disclose.
No disclosure on file
Julian Martinez Agosto, MD, PhD (University of California Los Angeles) Julian Martinez Agosto, MD, PhD has nothing to disclose.
No disclosure on file
No disclosure on file
Brent L. Fogel, MD, PhD, FÂé¶¹´«Ã½Ó³»­ (UCLA Neurology) Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Ataxia Foundation. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ataxia Global Initiative. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Genetics. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genes. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuromarkers. The institution of Dr. Fogel has received research support from the National Institutes of Health. The institution of Dr. Fogel has received research support from the National Ataxia Foundation. The institution of an immediate family member of Dr. Fogel has received research support from the National Institutes of Health, the National Science Foundation, and the Department of Defense. The institution of Dr. Fogel has received research support from US Department of Defense .